Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 12:16:1495997.
doi: 10.3389/fphar.2025.1495997. eCollection 2025.

Proanthocyanidins from Ginkgo extract EGb 761® improve bioenergetics and stimulate neurite outgrowth in vitro

Affiliations

Proanthocyanidins from Ginkgo extract EGb 761® improve bioenergetics and stimulate neurite outgrowth in vitro

Imane Lejri et al. Front Pharmacol. .

Abstract

EGb 761® is a proprietary extract from Ginkgo biloba leaves approved as an herbal medication for the treatment of dementia and its related disorders. Preclinical studies highlight antioxidant, ROS scavenging, mitochondria-stabilizing, and neuroplastic properties as some of the reported pharmacological activities. Efficacy is traditionally ascribed to terpene lactones and flavone glycosides. However, these quantified known active compounds in EGb 761® only cover approximately 30% of the mass balance, and there is the possibility that additional compounds from the residual 70% may enhance the activity of the quantified extract EGb 761®. Proanthocyanidins (PACs) are a quantitatively relevant component in EGb 761®, and some pharmacological activity has been reported for PACs from Ginkgo and other herbal sources. In this study, we focused on the effects of EGb 761® and its isolated PACs on mitochondrial bioenergetics and neuroplasticity in the human neuroblastoma cell line SH-SY5Y. We successfully demonstrated positive effects of EGb 761® and its isolated PACs on several mitochondrial characteristics and neurite outgrowth. As PACs exhibited similar effects compared to the respective extract concentration, they can be considered a pharmacologically relevant component of EGb 761®.

Keywords: EGb 761®; bioenergetics; mitochondria; neurite outgrowth; proanthocyanidins.

PubMed Disclaimer

Conflict of interest statement

AE has received honoraria for educational lectures and consulting fees from Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
EGb 761® and PACs decreased mitochondrial superoxide (A) and increased mitochondrial membrane potential (B) and ATP levels (C). Values represent the mean ± SEM of three independent experiments for (A) and five independent experiments for (B, C). Each open circle represents one replicate. Values were normalized to 100% of untreated CTRL cells. Statistical analysis was performed with ANOVA and post hoc Dunnett’s multiple comparisons test. *P < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.001 compared to control condition. CTRL, control; PACs, proanthocyanidins-fraction; EGb, EGb 761® extract.
FIGURE 2
FIGURE 2
EGb 761® and PACs increase metabolic activity (A) and mitochondrial (B) mass, while modulating the expression of PGC1-α (C) in SH-SY5Y cells. Optimal effects on metabolic activity and mitochondrial mass were achieved under the conditions of EGb 761® at 10 μg/mL and PACs at 1 μg/mL. Consequently, gene expression was evaluated under these respective conditions. Values represent the mean ± SEM of five independent experiments for (A) and three independent experiments for (B, C). Each open circle represents one replicate. Values were normalized to 100% of untreated CTRL cells. Statistical analysis was performed with ANOVA and post hoc Dunnett’s multiple comparisons test. *P < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.001 compared to the control condition. CTRL, control; PACs, proanthocyanidins-fraction; EGb, EGb 761® extract.
FIGURE 3
FIGURE 3
EGb 761® and PACs increase the oxygen consumption rate (OCR) (A) and extracellular acidification rate (ECAR) (B) in human neuroblastoma cells. Treatment with PACs at 1 μg/mL and EGb 761® at 10 μg/mL led to a more energetic state (C). Values represent the mean ± SEM of three independent experiments and six replicates per condition. Each replicate is measured in technical quadruplicates. Statistical analysis was performed with the unpaired t-test. *P < 0.05, **p < 0.01, and ****p < 0.001 compared to control condition. CTRL, control; PACs, proanthocyanidins-fraction; EGb, EGb 761® extract.
FIGURE 4
FIGURE 4
EGb 761® and PACs increased the neurite outgrowth in the human neuroblastoma cells. In total, approximately 10,000 cells and 57,000–101,000 neurites were evaluated. Images were taken with the Cytation 3 cell imaging multi-mode reader and analyzed with the ImageJ neurophology software to evaluate parameters of neuroplasticity. Values represent the mean ± SEM of three independent experiments and were normalized to the cell count. Data are presented as % normalized to the CTRL group. Per condition, 3,400–11,300 cells were analyzed in total. Each open circle represents one image. One way ANOVA and post hoc Dunnett’s multiple comparisons versus CTRL. *P < 0.05, **p < 0.01, and ***p < 0.001. CTRL, control; PACs, proanthocyanidins-fraction; EGB, EGb 761® extract.

Similar articles

References

    1. Abdel-Kader R., Hauptmann S., Keil U., Scherping I., Leuner K., Eckert A., et al. (2007). Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761). Pharmacol. Res. 56 (6), 493–502. 10.1016/j.phrs.2007.09.011 - DOI - PubMed
    1. Abdel-Kader R. M. (2009). Ginkgo biloba extract (EGb 761) in improving age-related and beta-amyloid induced neuronal dysfunctions. Johann Wolfgang Goethe-Universität. Available online at: https://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7230 .
    1. Anaya-Fernández R., Anaya-Prado R., Anaya-Fernandez M. M., Guerrero-Palomera M. A., Garcia-Ramirez I. F., Gonzalez-Martinez D., et al. (2024). Oxidative stress in cerebral ischemia/reperfusion injury. OBM Neurobiol. 08 (03), 1–15. 10.21926/obm.neurobiol.2403239 - DOI
    1. Bagchi D., Bagchi M., Stohs S. J., Das D. K., Ray S. D., Kuszynski C. A., et al. (2000). Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology 148, 187–197. 10.1016/s0300-483x(00)00210-9 - DOI - PubMed
    1. Barbalho S. M., Direito R., Laurindo L. F., Marton L. T., Guiguer E. L., Goulart R. d. A., et al. (2022). Ginkgo biloba in the aging process: a narrative review. Antioxidants 11 (3), 525. 10.3390/antiox11030525 - DOI - PMC - PubMed

LinkOut - more resources